VGXI Blog

VGXI was award the Vaccine Industry Excellence (ViE) Award for Best Contract Manufacturing Organization at the 6th Annual ViE Awards Ceremony held at the World Vaccine Congress on April 17th, 2013 in Washington, D.C. 

“Therapeutic plasmid DNA vector” is promising technology for the future of gene therapy. Though still in the clinical trial stage, DNA vaccines have great potential of being successful as effective vaccination technology with negligible side effects.

HPV (Human Papilloma Virus) Vaccines like GARDASIL® (marketed by Merck) and CERVARIX® (marketed by GlaxoSmithKline) have been widely available since 2006 and 2009, respectively. However, in an analysis of national survey data, 40% of parents in 2010 said that they did not intend to have their adolescent daughters vaccinated.

 This week’s blog article is geared towards technical writers and those of us who work or operate in a cGMP environment. We are all very familiar with the associated rules and regulations for “appropriate” documentation: not only must everything be documented scrupulously, the way we word our documents also plays a key role in how effective and accurate they are. In honor of all of that, here are some reminders on proper word usage for technical writing; it always helps to refresh our memories from time to time. How else can we ensure we are always staying on top of our game?

Scientists have published a new research paper in the journal Nature Materials that demonstrates that through the use of a pain-free microneedle patch, a DNA Vaccine can be delivered over 100 times more effectively than a regular needle injection.

Even though 2013 is already under way and there is a constant influx of new information, we wanted to make this an opportunity to look back at 2012 and relive some of our most memorable posts. So here they are, the 5 posts of 2012 that we have deemed the most interesting. Enjoy!

New looks into DNA editing have led researchers to discover a relatively simple, accurate, and cost-effective way to cut DNA in desired areas to remove faulty genes and replace them with genes that function properly.

Professor Ian Frazer, the man behind both of the HPV vaccines on the market today, Gardasil® (marketed by Merck & Co) and Cervarix® (marketed by GlaxoSmithKline), hasgone back to the drawing board to create a novel therapeutic HPV vaccine for Allied Healthcare Group’s investment company, Coridon.

Next up in our discussion of some of the major diseases plaguing human kind today is Malaria.

First of all, what is dengue?

For those of you fortunate enough to live in an area where dengue is not a major concern, you may not be terribly familiar with this widespread disease. In fact, the pronunciation of this mosquito-borne illness might even be a bit of a mystery.